Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
What is Cancer?02:12

What is Cancer?

10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Culture01:17

Stem Cell Culture

5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same author

Ionic-bridge engineered α-lactalbumin nanoparticles integrated into electrospun nanofibers for controlled growth factor delivery and burn wound repair.

Journal of nanobiotechnology·2026
Same author

Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Bioconjugate chemistry·2026
Same author

Engineering platelets as cancer therapeutics.

Nature reviews. Clinical oncology·2026
Same author

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy.

EJHaem·2025

相关实验视频

Updated: Jun 18, 2025

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.9K

工程细胞用于癌症治疗治疗.

Peixin Liu1,2,3, Quanyin Hu1,2,3

  • 1Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.

Accounts of chemical research
|August 2, 2024
PubMed
概括
此摘要是机器生成的。

工程细胞通过克服自然细胞的局限性,提供先进的癌症免疫疗法和组织修复. 这项研究探讨了针对性治疗的现场细胞工程,提高治疗疗效和减少副作用.

更多相关视频

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

158
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.4K

相关实验视频

Last Updated: Jun 18, 2025

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.9K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

158
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.4K

科学领域:

  • 生物医学工程 生物医学工程
  • 细胞工程 细胞工程
  • 癌症免疫疗法癌症免疫疗法

背景情况:

  • 活细胞在药物输送和组织修复方面具有前景,但在生产和成本方面面临挑战.
  • 生物和人工细胞旨在模仿细胞功能,但与复杂性和临床翻译作斗争.
  • 工程活细胞提供了增强的控制,以提高治疗疗效和减少副作用,从而实现精准医学.

研究的目的:

  • 为治疗应用工程细胞的最新进展提供全面的概述.
  • 突出用于现场细胞工程的新策略,以克服体外操纵的局限性.
  • 讨论工程细胞在癌症治疗和再生医学中的潜力.

主要方法:

  • 在基因编辑 (例如,CAR等离子体) 的纳米颗粒的水凝使用内源细胞的现场工程.
  • 用抗体对血小板进行表面修改,用于向药物输送和免疫治疗.
  • 工程细菌用于针对性地输送蛋白质药物,以诱导癌细胞通过热致死来死亡.

主要成果:

  • 成功准与瘤相关的巨细胞进行基因编辑,抑制质瘤复发.
  • 使用工程血小板抑制术后瘤复发和免疫治疗不可手术的瘤.
  • 诱导癌细胞死亡和免疫疗法通过工程细菌提供蛋白质药物.

结论:

  • 工程细胞,特别是通过现场操纵,显示出先进的癌症治疗和再生医学的重大前景.
  • 像CAR T细胞疗法,工程血小板和基于细菌的药物输送等策略提供了创新的方法来克服当前的治疗局限性.
  • 进一步的研究和开发对于临床翻译至关重要,解决可扩展性,成本效益和监管途径方面的挑战.